Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02138422
Recruitment Status : Completed
First Posted : May 14, 2014
Last Update Posted : March 1, 2021
Sponsor:
Information provided by (Responsible Party):
Janssen Research & Development, LLC